Go Deep
Vaidya Sane Ayurved Laboratories Limited
Vaidya Sane Ayurved Laboratories Limited Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 22,830 | 18.4 | 1.78 | 0.04 | 148.00 |
| Oct 2026 | 24,883 | 18.4 | 2.13 | 0.03 | 177.00 |
Vaidya Sane Ayurved Laboratories Limited Quarterly Results
Quarterly data isn't available for this company right now.
Vaidya Sane Ayurved Laboratories Limited Revenue & Profit: Last 5 Years
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Revenue | 1,069,064,000.0 | 899,229,000.0 | 993,313,000.0 | 991,689,000.0 | — |
| Net Profit | 89,866,000.0 | 71,361,000.0 | 19,804,000.0 | 48,329,000.0 | — |
| EPS | — | 6.8 | 2.0 | 4.6 | 8.0 |
Vaidya Sane Ayurved Laboratories Limited Balance Sheet
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Total Assets | 1,045,072,000.0 | 789,592,000.0 | 697,142,000.0 | 548,838,000.0 | — |
| Total Liabilities | 172,110,000.0 | 164,052,000.0 | 141,116,000.0 | 144,295,000.0 | — |
| Total Equity | 872,953,000.0 | 625,530,000.0 | 556,015,000.0 | 404,527,000.0 | — |
Owes vs Owns
Vaidya Sane Ayurved Laboratories Limited owed ₹0.16 for every ₹1 it owned in Mar 2026, down from ₹0.26 in Mar 2023.
| Period | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Owes vs Owns | 0.16× | 0.21× | 0.20× | 0.26× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Vaidya Sane Ayurved Laboratories Limited Assets & Liabilities Breakdown (₹ Cr)
What it owns — Mar 2026
Cash & short-term investments 22.1%Receivables 9.8%Inventory 3.5%Fixed assets (tangible) 23.0%Intangible assets 12.0%Other assets 29.5%
How it's funded — Mar 2026
Long-term debt 2.5%Payables 6.3%Other liabilities 7.7%Shareholders' equity 83.5%
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 23.1 | 15.7 | 18.4 | 15.6 |
| Receivables | 10.2 | 7.5 | 6.0 | 6.0 |
| Inventory | 3.6 | 3.8 | 4.1 | 3.4 |
| Fixed assets (tangible) | 24.1 | 22.7 | 23.0 | 20.1 |
| Intangible assets | 12.6 | 12.2 | 7.6 | 2.5 |
| Long-term investments | 0.0 | 0.0 | 1.0 | 1.5 |
| Other assets | 30.9 | 17.1 | 9.6 | 5.8 |
| Liabilities & equity | ||||
| Short-term debt | 0.0 | 1.5 | 1.7 | 0.1 |
| Long-term debt | 2.6 | 1.5 | 0.0 | 0.0 |
| Payables | 6.6 | 6.5 | 7.1 | 9.1 |
| Other liabilities | 8.1 | 6.9 | 5.3 | 5.2 |
| Shareholders' equity | 87.3 | 62.6 | 55.6 | 40.5 |
| Net tangible assets | 74.7 | 50.3 | 48.0 | 37.9 |
Vaidya Sane Ayurved Laboratories Limited Cash Flow
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Operating Activities | 54,114,000.0 | 257,036,000.0 | -12,583,000.0 | 641,000.0 | — |
| Investing Activities | -240,442,000.0 | -244,416,000.0 | -129,944,000.0 | 5,186,000.0 | — |
| Financing Activities | 167,100,000.0 | -12,741,000.0 | 148,613,000.0 | -13,796,000.0 | — |